Evidence map›Paper›PMID 29607398›Full record

ArticleEndoscopy international open2018

Clinicopathological examination of ESD as salvage therapy for esophageal cancer after definitive chemo-radiation therapy.

Tomo Kagawa, Shigenao Ishikawa, Tomoki Inaba, Mariko Colvin, Junki Toyosawa, Yuki Aoyama, Masaya Ishida, Sakiko Kuraoka, Kunio Okamoto, Ichiro Sakakihara and 10 more

Open access · goldAbstract read
In one paragraph

Article in Endoscopy international open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Tomo KagawaDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Shigenao IshikawaDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Tomoki InabaDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Mariko ColvinDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Junki ToyosawaDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Yuki AoyamaDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Masaya IshidaDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Sakiko KuraokaDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Kunio OkamotoDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Ichiro SakakiharaDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Koichi IzumikawaDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Kumiko YamamotoDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Sakuma TakahashiDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Shigetomi TanakaDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Mihoko MatsuuraDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Toshimi HasuiDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Masaki WatoDepartment of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Midori AndoDepartment of Pathology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Satoko NakamuraDepartment of Pathology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Koichi MizobuchiDepartment of Pathology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
Kagawa Prefectural Central Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND STUDY

aimsSalvage therapy for esophageal cancer following chemo-radiation therapy (CRT) has not been established. We aimed to evaluate endoscopic submucosal dissection (ESD) as a salvage therapy based on histopathological features of lesions. PATIENTS AND

methodsWe compared 10 lesions in eight patients with local residual, recurrent, or metachronous esophageal squamous cell carcinoma treated by ESD after CRT (CRT group) and 59 lesions treated by ESD without CRT (non-CRT group) during the same period.

resultsThe en bloc resection rate was 100 % while the complete resection rate was 80.0 % in the lesions after CRT, indicating no difference between the CRT and non-CRT groups. Pathological examination showed that fibrosis was more intense in the lamina propria mucosa, muscularis mucosa, and submucosa. The muscularis mucosa was thicker in both non-tumor and tumor sites in the CRT group compared to the non-CRT group. However, severe submucosal fibrosis was observed only in one lesion in the CRT group. The maximum diameter of the submucosal artery was significantly larger in the CRT group (

conclusionsCompared to the non-CRT group, the lesions in the CRT group were accompanied by fibrosis while the muscularis mucosa were thicker; however, severe fibrosis of the submucosa was rare. It is important to dissect the muscularis mucosa appropriately during ESD, which makes successful dissection of the submucosa possible. Attention should be paid to bleeding from large arteries.

Identifiers

PMID29607398
PMCPMC5876030
OpenAlexW2794980694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.